Influence of endostatin on embryonic vasculo- and angiogenesis.
The proteolytic fragment of collagen XVIII, endostatin, acts as an inhibitor of angiogenesis. To date, only limited knowledge exists on the effects of endostatin on endothelial cells during embryonic development. Therefore, we analysed the role of endostatin on embryonic vasculo- and angiogenesis. Endostatin is accumulated in embryonic tissue of mouse embryos. Similarly, in vessels of embryoid bodies (EBs), endostatin and its binding sites are distributed in vessels and sprouting areas. In EBs, endostatin increases endothelial cells (control, 279.3 +/- 76.5; 50 ng/ml, 566.3 +/- 90.1; 200 ng/ml, 594.5 +/- 166.3 tube-like structures per EB) and endothelial tubes by proliferation (control, 21.4 +/- 7.5; 50 ng/ml, 160.2 +/- 9.9; 200 ng/ml, 184.2 +/- 16.5 Ki67-positive nuclei per 50 tube-like structures); it also enhances migration (control, 380.5 +/- 159.8 cells; 50 ng/ml, 718.3 +/- 251 cells; 200 ng/ml, 706 +/- 89.4 cells) and apoptosis (control, 16.8 +/- 6.7; 50 ng/ml, 94.4 +/- 23.6; 200 ng/ml, 106 +/- 42 PARP-positive nuclei per 50 tube-like structures). Furthermore, endostatin modulates the morphology of the endothelial tubes by inducing contraction. Endostatin modulates the embryonic vascular development by enhancing proliferation, migration, and apoptosis as well as by regulating morphogenesis.
Schmidt
Annette
A
Department of Molecular and Cellular Sport Medicine, German Sport University Cologne, Cologne, Germany.
Wenzel
Daniela
D
Ferring
Isabell
I
Kazemi
Shohreh
S
Sasaki
Takako
T
Hescheler
Jürgen
J
Timpl
Rupert
R
Addicks
Klaus
K
Fleischmann
Bernd K
BK
Bloch
Wilhelm
W
D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D001665:Binding Sites; D015415:Biomarkers / Q000378:metabolism; D001755:Blastocyst / Q000166:cytology; D002454:Cell Differentiation; D002455:Cell Division / Q000187:drug effects; D019070:Cell Lineage; D002465:Cell Movement / Q000187:drug effects; D002467:Cell Nucleus / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004622:Embryo, Mammalian; D043169:Endostatins / Q000378:metabolism / Q000494:pharmacology*; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects* / Q000196:embryology* / Q000378:metabolism; D006801:Humans; D019394:Ki-67 Antigen / Q000378:metabolism; D051379:Mice; D009024:Morphogenesis; D018919:Neovascularization, Physiologic / Q000187:drug effects*; D011485:Protein Binding; D011994:Recombinant Proteins / Q000494:pharmacology; D013234:Stem Cells / Q000166:cytology; D013997:Time Factors; D014471:Umbilical Veins / Q000166:cytology
D015415:Biomarkers; D043169:Endostatins; D019394:Ki-67 Antigen; D011994:Recombinant Proteins